(Q39004090)

English

In vitro and in silico evaluation of NF-κB targeted costunolide action on estrogen receptor-negative breast cancer cells--a comparison with normal breast cells

scientific article published on 15 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

In vitro and in silico evaluation of NF-κB targeted costunolide action on estrogen receptor-negative breast cancer cells--a comparison with normal breast cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

estrogen-receptor negative breast cancer

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Daisy Pitchai

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Anita Roy

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sakhila Banu

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

15 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Phytotherapy Research

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1499-1505

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Antimicrobial activity of sesquiterpene lactones isolated from traditional medicinal plant, Costus speciosus (Koen ex.Retz.) Sm.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Antioxidant activity of costunolide and eremanthin isolated from Costus speciosus (Koen ex. Retz) Sm.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Normo-glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.)Sm. in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Costunolide, a sesquiterpene lactone from Saussurea lappa, inhibits the VEGFR KDR/Flk-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

NF-kappaB and IKK as therapeutic targets in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Costunolide induces apoptosis in human endometriotic cells through inhibition of the prosurvival Akt and nuclear factor kappa B signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Naturally occurring NF-kappaB inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Synthesis of 13-amino costunolide derivatives as anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5155

21 January 2018

Identifiers

10.1002/PTR.5155

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39004090&oldid=2170371536"